Christopher Wiggins is the politics and news editor at equalpride, where he leads and shapes coverage across The Advocate, Out, and Them. Based in Washington, D.C., he oversees national reporting on ...

Not every sales pitch for a reverse mortgage is worth your time. Retirees are the target demographic for reverse mortgages — a tool that can tap their home’s equity for cash. But it's important to be ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Crypto exchanges are rapidly expanding into traditional finance by offering perpetual futures tied to stocks, indexes and commodities, with trading volume surging to $1.32 trillion in the first five ...

Blue Owl Capital’s data center firm Stack Infrastructure Inc. is seeking an A$8.5 billion ($5.9 billion) syndicated loan to fund its latest project in Melbourne, according to people familiar with the ...

On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...

OKLAHOMA CITY—On a Saturday afternoon about 20 hours before he was due to preach, Darrell Stetler II sat behind a two-monitor workstation crammed into the sound booth of his church, a slide deck ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...